# Transnasal Induction of Normothermia for Neurogenic Fever

> **NCT06038513** · NA · TERMINATED · sponsor: **CoolTech LLC** · enrollment: 9 (actual)

## Conditions studied

- Stroke, Ischemic
- Stroke Hemorrhagic
- Seizures
- Metabolic Encephalopathy

## Interventions

- **DEVICE:** Transnasal Thermal Regulating Device

## Key facts

- **NCT ID:** NCT06038513
- **Lead sponsor:** CoolTech LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-11-21
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-11-30
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Insufficient accrual
- **Last updated:** 2026-01-26

## Collaborators

- Maryland Industrial Partnerships

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06038513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06038513, "Transnasal Induction of Normothermia for Neurogenic Fever". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06038513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*